D

Dren Bio, Inc.

50 employees

Dren Bio focuses on protein engineering technologies for depletion of cells, protein aggregates, and other disease-causing agents.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Biotechnology and Antibody
Life Science

Date founded

2019

Funding rounds raised

Total raised

$65M

from 7 investors over 7 rounds

D

Dren Bio, Inc. raised $65M on June 14, 2022

Investors: HBM Partners AG, Revelation Partners, S.R. One Ltd and Mission BioCapital

D

Dren Bio, Inc. raised $60M on October 16, 2020

Investors: 8VC, Mission BioCapital and S.R. One Ltd

FAQ